Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Larimar Therapeutics Inc. buy DomRuinart

Start price
€17.12
01.12.20 / 50%
Target price
€20.00
01.12.21
Performance (%)
5.26%
End price
€18.02
14.12.20
Summary
This prediction ended on 14.12.20 with a price of €18.02. With a performance of 5.26%, the BUY prediction by DomRuinart for Larimar Therapeutics Inc. closed with a slight gain. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Larimar Therapeutics Inc. -6.107% -6.107% 49.272% -28.488%
iShares Core DAX® 2.112% -0.367% 13.466% 16.854%
iShares Nasdaq 100 -2.197% -3.794% 38.426% 42.934%
iShares Nikkei 225® -1.555% -7.320% 18.451% 2.941%
iShares S&P 500 -0.472% -2.078% 27.488% 41.955%

According to DomRuinart what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread Zafgen Inc. diskutieren
Prediction Buy
Perf. (%) 5.26%
Target price 20.000
Change
Ends at 01.12.21

Buy mit Kursziel 20,0

In the thread Trading Zafgen Inc.
Prediction Buy
Perf. (%) 5.26%
Target price 20.000
Change
Ends at 01.12.21

Buy beendet

Stopped prediction by DomRuinart for Larimar Therapeutics Inc.

buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.50
19.04.21
€15.00
19.04.22
29.41%
03.05.21

Could be worthwhile Investment >10% per year